These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 7032828

  • 21. An ambulatory trial of guanfacine.
    Mann S, Millar Craig MW, Melville DI, Cashman PM, Raftery EB.
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):103S-107S. PubMed ID: 6994762
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A postmarketing evaluation of guanfacine hydrochloride in mild to moderate hypertension.
    Board AW, Perry VP, Shepperson BE, Nyman CE, Carchman SH.
    Clin Ther; 1988; 10(6):761-75. PubMed ID: 3064907
    [Abstract] [Full Text] [Related]

  • 26. Usefulness of low dose guanfacine, once a day, for 24-hour control of essential hypertension.
    Keenan RE, Black PL, Freudenburg JC, Hill JA, Holmburg CE, Reitbrock MJ, Sullivan MJ, Thompson MT, Wright DL.
    Am J Cardiol; 1986 Mar 28; 57(9):38E-42E. PubMed ID: 3513529
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Evaluation of guanfacine and clonidine in essential hypertension: a single-blind crossover study.
    Miach PJ, Louis WJ.
    Med J Aust; 1980 Oct 04; 2(7):395-6. PubMed ID: 7005630
    [Abstract] [Full Text] [Related]

  • 29. Hypotensive effect of guanfacine in essential hypertension: a comparison with clonidine.
    Lauro R, Reda G, Spallone L, Anguissola AB.
    Br J Clin Pharmacol; 1980 Oct 04; 10 Suppl 1(Suppl 1):81S-82S. PubMed ID: 6994784
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Clinical dose-response studies with guanfacine (BS 100-141), a new antihypertensive agent.
    MacCarthy P, Isaac P, Frost G, Freeman A, Stokes G.
    Clin Exp Pharmacol Physiol; 1978 Oct 04; 5(2):187-90. PubMed ID: 348364
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Hemodynamic effects of guanfacine in essential hypertension.
    Feldstein CA, Cohen AA, Sabaris RP, Burucúa JE.
    Clin Ther; 1984 Oct 04; 6(3):325-34. PubMed ID: 6373009
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Controlled doubleblind study on dose-effect relationship of guanfacine a long-acting hypotensive guanidine derivative (author's transl)].
    Magometschnigg D, Bonelli J, Hitzenberger G, Kaik G.
    Arzneimittelforschung; 1980 Oct 04; 30(6):1005-7. PubMed ID: 6998487
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Comparison of effects of guanfacine and clonidine on blood pressure, heart rate, urinary catecholamines, and cyclic nucleotides during and after administration to patients with mild to moderate hypertension.
    Nami R, Bianchini C, Fiorella G, Chierichetti SM, Gennari C.
    J Cardiovasc Pharmacol; 1983 Oct 04; 5(4):546-51. PubMed ID: 6193349
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.